Cyclophilin A and EMMPRIN (CD147) in cardiovascular diseases

被引：73
|
作者：
Seizer, Peter [1 ]
Gawaz, Meinrad [1 ]
May, Andreas E. [1 ]
机构：
[1] Univ Tubingen, Med Klin 3, Kardiol & Kreislauferkrankungen, D-72076 Tubingen, Germany
来源：
CARDIOVASCULAR RESEARCH | 2014年 / 102卷 / 01期
关键词：
EMMPRIN; Cyclophilin A; Inflammation; METALLOPROTEINASE INDUCER EMMPRIN; LOW-DENSITY LIPOPROTEINS; CD4(+) T-CELLS; EXTRACELLULAR CYCLOPHILIN; CYCLOSPORINE-A; INFLAMMATION; PLATELETS; EXPRESSION; SECRETION; MONOCYTES;
D O I：
10.1093/cvr/cvu035
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Cyclophilin A(CyPA) is an abundantly expressed intracellular protein. It exerts a variety of functions due to its peptidyl-prolylcis-trans isomerase (PPIase) activity. When released into the extracellular space, CyPA binds to its extracellular receptor CD147 (EMMPRIN) and thereby initiates a cascade of inflammatory processes. Recent data indicate that both extra-and intracellular CyPA significantly contribute to cardiovascular inflammation, myocardial ischaemia and reperfusion injury, and myocardial remodelling processes. Thus, CyPA appears to represent a novel target to treat vascular and myocardial inflammation.
引用
收藏
页码：17 / 23
页数：7
相关论文
共 50 条
  • [21] Immunohistochemical expression of EMMPRIN (CD147) in oral squamous cell carcinoma
    Sahaf, Rakia
    Naseem, Nadia
    Rehman, A. U.
    Anjum, Rabia
    Nagi, Abdul Hanan
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY MEDICINE AND PATHOLOGY, 2018, 30 (01) : 67 - 73
  • [22] Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy
    Han, Jang Mi
    Jung, Hye Jin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [23] The role of EMMPRIN/CD147 in regulating angiogenesis in patients with psoriatic arthritis
    Rahat, Michal A.
    Safieh, Mirna
    Simanovich, Elina
    Pasand, Eliran
    Gazitt, Tal
    Haddad, Amir
    Elias, Muna
    Zisman, Devy
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [24] Basigin (EMMPRIN/CD147) interacts with integrin to affect cellular architecture
    Curtin, KD
    Meinertzhagen, IA
    Wyman, RJ
    JOURNAL OF CELL SCIENCE, 2005, 118 (12) : 2649 - 2660
  • [25] EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair
    Gabison, EE
    Hoang-Xuan, T
    Mauviel, A
    Menashi, S
    BIOCHIMIE, 2005, 87 (3-4) : 361 - 368
  • [26] EMMPRIN (CD147). A prognostic and potentially therapeutic marker in urothelial cancer
    Nawroth, R.
    Hartmann, A.
    Wild, P.
    Lehmann, J.
    Stoehr, R.
    Gschwend, J. E.
    Retz, M.
    PATHOLOGE, 2010, 31 : 251 - 254
  • [27] EMMPRIN (basigin/CD147) is involved in the morphogenesis of tooth germ in mouse molars
    Xie, Ming
    Jiao, Ting
    Chen, Yuqin
    Xu, Chun
    Li, Jing
    Jiang, Xinquan
    Zhang, Fuqiang
    HISTOCHEMISTRY AND CELL BIOLOGY, 2010, 133 (05) : 585 - 594
  • [28] Expression of CD147 and Cyclophilin A in Kidneys of Patients with COVID-19
    Su, Hua
    Wan, Cheng
    Wang, Zhen-Di
    Gao, Yong
    Li, Yun-Cheng
    Tang, Fang
    Zhu, Hong-Yan
    Yi, Li-Xia
    Zhang, Chun
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (04): : 618 - 619
  • [29] EMMPRIN/CD147 plays a detrimental role in clinical and experimental ischemic stroke
    Patrizz, Anthony
    Doran, Sarah J.
    Chauhan, Anjali
    Ahnstedt, Hilda
    Roy-OReilly, Meaghan
    Lai, Yun-Ju
    Weston, Gillian
    Tarabishy, Sami
    Patel, Anita R.
    Verma, Rajkumar
    Staff, Ilene
    Kofler, Julia K.
    Li, Jun
    Liu, Fudong
    Ritzel, Rodney M.
    McCullough, Louise D.
    AGING-US, 2020, 12 (06): : 5121 - 5139
  • [30] Inhibition of EMMPRIN (CD147) sensitizes human breast cancer cells to anoilkis
    Yang, J.
    O'Neill, P.
    Jin, W.
    Foty, R.
    Lomas, M.
    Arndt, G.
    Tang, Y.
    Nakada, M.
    Yan, L.
    Halt, W.
    EJC SUPPLEMENTS, 2006, 4 (12): : 146 - 146
12345